Posts by odiadmin
Patent Enforcement Notice
Cease & Desist notice issued to owners of a Colorado-based website, www.pingueculaeyedrops.com which was infringing Ocular Discovery’s US patents by offering dipyridamole-containing eye drops. The infringers have ceased sales of their infringing product and transferred ownership of their domains to Ocular Discovery Ltd.
Read MoreFifth U.S. Patent Granted
Fifth patent allowance issued in the United States, toward the use of topical dipyridamole for the treatment of melanocytic nevus, cataracts, and ocular melanoma.
Read MoreResearch Partnership with the Dr. R.P. Centre for Ophthalmic Sciences at All Institute of Medical Sciences, New Delhi (AIIMS)
Ocular Discovery launches novel research partnership with India’s leading eye care hospital, the Dr. R.P Centre for ophthalmic sciences, to investigate the mechanism of action of Dipyridamole in Ocular Surface Disorders. To view the official press release.
Read MoreFourth U.S. Patent Granted
Fourth patent allowance issued in the United States, the for the use of dipyridamole in the following indications: keratitis, corneal abrasions, and corneal ulcers
Read MorePterygium Trial Recruitment Completed
Patient recruitment complete in India for trial exploring the use and effectiveness of Dipyridamole eye drops for the symptomatic treatment of Pterygium. Trial completion expected by May 2019
Read MorePatent Granted in China
Patent allowance issued in China for the indications of Dry Eye Disease, Sjogren’s Syndrome, Pterygium, Pinguecula, and Corneal Neovascularization
Read MoreThird U.S. Patent Granted
Third patent allowance issued in the United States for the indication of Conjunctivitis
Read MorePatent Granted in Australia
Patent allowance issued in Australia for the indication of Lacrimal and Anterior Eye Segment Disorders
Read MoreAnti-Angiogenic Experiments Successful
Preclinical experiments support the anti-angiogenic effects of Ocular Discovery’s Dipyridamole drops
Read MoreSecond U.S. Patent Granted
Second patent allowance issued in the USA for the treatment of Pterygium, Pinguecula, and Corneal Neovascularization
Read More